Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study
Open Access
- 5 January 2020
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica
- Vol. 61 (9) , 1196-1204
Abstract
Background: Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has been proven to be a good method to detect distant spread of head and neck cancer (HNC). However, most prior studies are based on Asian populations and may not be directly transferable to western populations. Purpose: To investigate the frequency and distribution of distant metastases and synchronous malignancies detected by PET/CT in HNC in a northern Swedish population. Material and Methods: All primary whole-body FDG-PET/CT examinations performed on the suspicion of HNC (n = 524 patients) between 1 January 2013 and 31 December 2016 at Umeå University Hospital in Sweden were retrospectively reviewed . After the exclusion of 189 examinations without evidence of primary HNC, 335 examinations were analyzed. Results: Distant metastases were detected in 10 (3%) patients, all with advanced primary tumors corresponding to TNM stage 3–4, most frequently in salivary gland adenocarcinoma, where 50% of patients had distant spread. Four patients had metastases below the diaphragm, representing 20% of the salivary gland malignancies. In the remaining six patients, metastases were supraphrenic, of which all but one were identified by CT alone. Synchronous malignancies were discovered in 14 (4.2%) patients, of which five were below the diaphragm. Conclusion: The overall frequency of distant spread and synchronous malignancy in primary HNC was generally low. However, the risk for distant metastases below the diaphragm was relatively higher in salivary gland adenocarcinoma, supporting whole-body FDG-PET/CT in the primary diagnostic work-up in these patients.Keywords
Funding Information
- Regional agreement between Umeå University and Västerbotten County Council on cooperation in the field of Medicine, Odontology and Health. (ALF) (RV-680601, RV-864811)
This publication has 29 references indexed in Scilit:
- 18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysisOral Oncology, 2011
- Positron Emission Tomography With [18F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective StudyJournal of Clinical Oncology, 2010
- Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trialRadiotherapy and Oncology, 2008
- Identification of Distant Metastases With Positron–Emission Tomography‐Computed Tomography in Patients With Previously Untreated Head and Neck CancerThe Laryngoscope, 2008
- Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancerAnnals of Oncology, 2007
- Role of 18F-FDG PET/CT in Management of High-Grade Salivary Gland MalignanciesJournal of Nuclear Medicine, 2007
- Efficacy of Radiologic Screening for Distant Metastases and Second Primaries in Newly Diagnosed Patients With Head and Neck CancerThe Laryngoscope, 2007
- FDG‐PET in the Clinically Negative Neck in Oral Squamous Cell CarcinomaThe Laryngoscope, 2006
- Screening for distant metastases in patients with head and neck cancer: Is there a role for 18FDG-PET?Oral Oncology, 2006
- Incidence and Sites of Distant Metastases from Head and Neck CancerORL, 2001